Marex Group plc
Paolo Tonucci (See Remarks) sells MRX shares
About this filing
Marex Group plc (MRX) filed Form 4 (insider transaction) with the SEC on Nov 12, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Paolo Tonucci · See Remarks
Rule 10b5-1 plan
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | S · open-market saleFootnotes F1, F2 | −3,196 | $67.89 | $216,980.91 | 1,249,709 | Direct |
| Nov 9, 2026 | S · open-market saleFootnotes F1, F3 | −10,760 | $68.74 | $739,595.06 | 1,238,949 | Direct |
| Nov 9, 2026 | S · open-market saleFootnotes F1, F4, F5 | −2,712 | $69.41 | $188,228.53 | 1,236,237 | Direct |
Footnotes
- F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
- F2 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5 The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Remarks: Chief Strategist and CEO, Capital Markets
More MRX filings
- 4
Filed Nov 19, 2026
- 144
Filed Nov 17, 2026
- 4
Filed Nov 17, 2026
- 424B2
Filed Nov 16, 2026
- 13F-HR
Filed Nov 16, 2026
- 3
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.